WBMT Workshop and 3. Scientific Symposium, Cape Town

Cape Town, Survey report, October 2014

________________________________________________________________________

November 14, morning
Welcome by: Professor Yoshihisa Kodera (President WBMT)
WHO and HTC: Legal and ethical aspects
Global Perspectives of Hematopoetic Stem Cell Transplantation including Macroeconomics
Overview of Hematopoietic Stem Cell Transplantation in Africa
Regional Activity Report, South Africa
Regional Activity Report, Egypt
Regional Activity Report, Tunisia
Regional Activity Report, Algeria
Regional Activity Report, Marocco
Regional Activity Report, Nigeria
The Role of Citizens to create a Stem Cell Donor Banking System
Introduction to the Workshop: Explanation of Program

November 14, afternoon
Autologous vs allogenic HSCT to get started
Roundtable Discussion

November 14, late afternoon
Regulatory Framework for Cells and Tissues
Setting up a Regulatory Framework for Blood in Africa
Patient Selection for HCT
Who needs a transplant? Indications for HCT
Bone Marrow Transplant in Hemoglobinopathies
Human Tissue Legislation

November 15, morning
Pros and Cons of Stem Cell Sources and their availability in Africa
HLA Typing, Donor Selection and Donor Registries
Donor safety including minors as donors
Roundtable discussion: Donor selection and donor safety

Training and dissemination of knowledge
My experience in trainig abroad
Bone Marrow Registry in Nigeria: Update

November 15, afternoon
Session on Blood Transfusion
Access to safe and effective blood transfusion including blood component therapy
Safe Blood supply during Infectious disease outbreaks
Cell processing
Graft processing across Africa: What is available?
Hematopoietic Progenitor Cell Graft Processing & Testing

November 15, late afternoon
Creating a Quality System that works
Overview of Standards setting in HCT
Essential Elements: A Guide For Establishing a Complete Quality Program. Cells & Tissues for Administration
Where do we first start?
From following standards to successfully obtaining accreditation
The Role of Outcomes Registries in Blood and Marrow Transplantation
Outcome Registries : Challenges
WBMT Global Survey
The South African Bone Marrow Registry: Helping the People of Africa
Concluding Remarks
________________________________________________________________________

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? – E. Gluckman

Haploidentical HSCT from Family Members – Dietger Niederwieser

Haplo-identical HCT: Asian experience, Yoshihisa Kodera

Transplantation for Leukemia: How much regimen intensity is needed?,
Daniel Weisdorf

Bacterial and fungal infections after HCT – Wieslaw Wiktor-Jedrzejczak

Prophylaxis and treatment of viral infections in HSCT– Diana Hardie

Management of HIV in the peri-transplant period– Graeme Meintjes

Early Organ Toxicity Post HCT –Wael Saber

Acute Graft-versus-host disease – Hildegard Greinix

Chronic Graft-versus-Host Disease – Jörg Halter

Complications of HCT: Late Effects – Naeem A Chaudhri

Critical early complications of HSCT: management and treatment of Veno-Occlusive Disease

Hematopoietic Stem Cell Transplantation for Thalassemia Major, Alok Srivastava

Hematopoietic cell transplantation in bone marrow failures, Menachem Bitan

T-CELL DEPLETION: ALEMTUZUMAB IN THE BAG, Nicolas Novitzky

Allogeneic HCT in leukemia and lymphoma, Wiesaw Wiktor-Jedrzejczak

Allogeneic HSCT for pediatric malignant diseases, Adriana Seber

HSCT in Burkitt Lymphoma, Syed Osman Ahmed

Hematopoietic cell transplantation for multiple myeloma, Marcelo C. Pasquini